Inotuzumab ozogamicin, CAS [[635715-01-4]]

Produktübersicht

• Artikelname: Inotuzumab ozogamicin, CAS [[635715-01-4]]
• Artikelnummer: MCE-HY-P9959
• Hersteller Artikelnummer: HY-P9959
• Alternativnummer: MCE-HY-P9959-100UG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: CMC-544, PF-5208773, WAY-207294

Produktbeschreibung

Inotuzumab ozogamicin (CMC-544) is an antibody-targeted chemotherapy agent composed of a humanized anti-CD22 antibody conjugated to Calicheamicin (HY-19609). Inotuzumab ozogamicin and G544 bind human CD22 with similar affinities (Kd ~ 150 pM). Inotuzumab ozogamicin has demonstrated efficacy against CD22+ B-cell non-Hodgkins lymphoma. Inotuzumab ozogamicin can be used in the research of acute lymphoblastic leukemia[1][2][3].

Produkteigenschaften

• Reinheit: 99.7
• CAS Nummer: [635715-01-4]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs),CD22

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies